The WHO R&D Blueprint team for Epidemics is organizing a global consultation to discuss Plague: What R&D progress has been achieved and how can we accelerate the development of a vaccine? scheduled for 12 October 2023 (13:00 – 18:00 CET)
During this forthcoming consultation, global experts will present recent epidemiology updates, then review the evidence from developmental vaccine studies to enumerate knowledge gaps and outline research priorities related to plague vaccines.
- The objectives of the meeting are to:
- Review the epidemiological situation.
- Review salient animal models and immunology of protection against plague
- Discuss the developmental progress of plague vaccines in the pipeline.
- Review scientific approaches for their clinical evaluation.
- Identify knowledge gaps and research priorities.
It was a global OPEN meeting.
PRESENTATIONS
Thursday 12 October 2023
- Plague in Latin America by Ana Rivière Cinnamond
- Overview of the Epidemiological Situation of Plague in EMR countries by Chiori Kodama
- Overview of Plague Epidemiology in Asia by Gyanendra Gongal
- Plague in the African Region by Reena Doshi
- Plague in the WHO European Region by Richard Pebody
- WHO-Plague Vaccines in Preclinical Development and Clinical Trials by Ashok K. Chopra
- Clinical Trials of a Plague Vaccine in China by Jingxin Li
- Plague vaccination in Mongolia by Uyanga Baasandagva
- WHO Meeting rF1V Vaccine DOD Dvax Final by Wai Chung
- Animal models for plague vaccine testing by Andrey P. Anisimov
- Plague Vaccine Trials Design by Ira Longini
- Animal model challenges by Judy Hewitt
- WHO Technical Advisory Group for Candidate Vaccine Prioritization by Mike Levine
- Target Product Profiles by Ximena Riveros